By Metro US
Posted on
WASHINGTON (Reuters) – The U.S. purchased 200 million more doses of the Pfizer/BioNTech vaccine for flexibility if booster shots are later needed and the shots are approved for younger children, the White House said on Friday.
The vaccine makers announced the government’s purchase earlier on Friday.
(Reporting by Jeff Mason and Trevor Hunnicutt; Editing by Chris Reese)
Bruins beat Maple Leafs 4-2 in Game 3 to take series lead
Herro scores 24, Heat hit franchise playoff-record 23 3s to beat Boston and even series 1-1
Shohei Ohtani has 3 doubles, Landon Knack gets 1st victory as Dodgers rout Nationals 11-2
Cubs reliever Luke Little forced to change his glove because of white in American flag patch
Minnesota’s Naz Reid wins NBA’s Sixth Man of the Year award, edging Malik Monk in close vote
US coalition warship shoots down missile fired by Yemen’s Houthi rebels over the Gulf of Aden
A look at the Gaza war protests that have emerged on US college campuses
Blinken raises Chinese trade practices in meetings with officials in the financial hub of Shanghai
A high-profile murder trial in Kazakhstan boosts awareness of domestic violence
Venice launches experiment to charge day-trippers an access fee in bid to combat over-tourism
UN report says 282 million people faced acute hunger in 2023, with the worst famine in Gaza
US abortion battle rages on with moves to repeal Arizona ban and a Supreme Court case
US births fell last year, marking an end to the late pandemic rebound, experts say
Relatives of those who died waiting for livers at now halted Houston transplant program seek answers
